Board on Health Sciences Policy, Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation, Institute of Medicine (U.S.), Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products (Workshop), Caruso, D., English, R. A., & Claiborne, A. B. (2014). Characterizing and communicating uncertainty in the assessment of benefits and risks of pharmaceutical products: Workshop summary. The National Academies Press.
Cita Chicago Style (17a ed.)Board on Health Sciences Policy, Development Institute of Medicine (U.S.). Forum on Drug Discovery, Institute of Medicine (U.S.), Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products (Workshop), Denise Caruso, Rebecca A. English, y Anne B. Claiborne. Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products: Workshop Summary. Washington, District of Columbia: The National Academies Press, 2014.
Cita MLA (9a ed.)Board on Health Sciences Policy, et al. Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products: Workshop Summary. The National Academies Press, 2014.
